Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07010601 · ClinicalTrials.gov registry record · NA
Tobacco Product Susceptibility and Substitutability by Rurality and Alcohol Use
A NA study of Alcohol Use and E-cigarette Use, sponsored by Mark J Rzeszutek, PhD.
- Completed
- Registry status
- NA
- Development phase
- 737
- Enrollment target
- 1
- Study location
NCT07010601: Completed NA study of Alcohol Use and E-cigarette Use, sponsored by Mark J Rzeszutek, PhD.
NCT07010601 is a NA study of Alcohol Use and E-cigarette Use that has completed, run by Mark J Rzeszutek, PhD. The registered enrollment target is 737 participants, above the 238-participant average among 23 other Alcohol Use trials with a reported enrollment target (210% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07010601, a NA study of Alcohol Use and E-cigarette Use, has completed, sponsored by Mark J Rzeszutek, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 737 participants
- Enrollment target
- 1
- Study location
Study Summary
A high priority research area for the Food and Drug Administration Center for Tobacco Products (FDA CTP) is determining who will start using tobacco products and who will stop using tobacco products. A population that has a disproportionately high amount of tobacco use are people living in rural areas. This indicates that some aspect of rurality is related to tobacco product susceptibility and decreased tobacco cessation rates. People in rural areas also typically have higher rates of alcohol use, which is also associated with higher tobacco use and decreased tobacco cessation rates. The purpose of this study is to (1) examine how rurality and alcohol use may affect susceptibility to existing and novel tobacco products and (2) examine how rurality and alcohol use may affect likelihood for tobacco users to substitute to tobacco cessation products. To accomplish this, the investigators will use behavioral economic measures to assess how people respond to novel tobacco products (high and low nicotine, flavored and unflavored), as well as use the experimental tobacco marketplace to determine how current users might switch to products associated with cessation. Because rurality is a spectrum, the investigators will be using an index of relative rurality (IRR) to better quantify how rurality and alcohol use affect these tobacco-related behaviors.
Primary Outcome
Likelihood to purchase and consume hypothetical nicotine products and sensitivity to cost of different product categories, flavors, and nicotine combinations will be assessed in all groups. Hypothetical demand will be assessed using non-linear mixed-effects modeling to obtain estimates of demand intensity and price sensitivity for these hypothetical products. Higher intensity and lower price sensitivity are indicators for higher subjective value and likelihood to try these novel products.
Conditions Studied
Interventions
- BEHAVIORAL Experimental Tobacco Marketplace
- BEHAVIORAL Hypothetical Novel Nicotine Product Purchase Tasks
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 737 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2025-08-20 |
| Phase | NA |
What the finished NCT07010601 record still lists
NCT07010601 is an interventional study that assigns participants to a tested intervention. The registered 737 participants enrollment target is mid-sized for trials with a published cap, above the 238-participant average among 23 other Alcohol Use trials with a reported enrollment target (210% higher).
The record links to 3 conditions, with Alcohol Use appearing as the primary indexed condition, and to 2 interventions - of which Experimental Tobacco Marketplace is the first listed.
NCT07010601 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07010601 about?
NCT07010601 is a clinical study titled "Tobacco Product Susceptibility and Substitutability by Rurality and Alcohol Use". A high priority research area for the Food and Drug Administration Center for Tobacco Products (FDA CTP) is determining who will start using tobacco products and who will stop using tobacco products. A population that has a disproportionately high amount of tobacco use are people living in rural are...
What is the current status of trial NCT07010601?
This trial is currently completed. It is a NA study. The enrollment target is 737 participants. The study started on 2025-08-18. Estimated completion is 2025-08-20.
What conditions does trial NCT07010601 study?
This clinical trial studies the following conditions: Alcohol Use, E-cigarette Use, Cigarette Use.
What interventions are being tested in trial NCT07010601?
The interventions under investigation include: Experimental Tobacco Marketplace (BEHAVIORAL), Hypothetical Novel Nicotine Product Purchase Tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT07010601?
This trial is sponsored by Mark J Rzeszutek, PhD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07010601 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07010601's enrollment target sits among peer trials
737 3rd of 23 higher than 21 of 23 other Alcohol Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Wellness, Alcohol, Vitals, and Emotions
RECRUITING · NA
-
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
RECRUITING · NA
-
Stress and Resilience
RECRUITING · NA
-
The Less is More Study
RECRUITING · NA
-
Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05796141 · 736 participants · NA
Becoming United in Lifestyle Decisions
- NCT03723928 · 739 participants · NA
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- NCT05947851 · 735 participants · Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- NCT05999084 · 735 participants
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI